In cases of asthma characterized by an imbalance in Th17/Treg immune response, Chinese medicine has been shown to impact eosinophilic asthma by reducing levels of cytokines such as IL-17A, INF-γ, TGF-β, and ROR-γ. This evidence concerns the gene TGFB1 and asthma.